Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Parasite genotyping by the polymerase chain reaction was used to distinguish recrudescent from newly acquired Plasmodium falciparum infections in a Karen population resident on the northwestern border of Thailand where malaria transmission is low (one infection/person/year). Plasmodium falciparum infections were genotyped for allelic variation in three polymorphic antigen loci, merozoite surface proteins-1 and -2 (MSP-1 and -2) and glutamaterich protein (GLURP), before and after antimalarial drug treatment. Population genotype frequencies were measured to provide the baseline information to calculate the probability of a new infection with a different or the same genotype to the initial pretreatment isolate. Overall, 38% of the infections detected following treatment had an identical genotype before and up to 121 days after treatment. These post-treatment genotypes were considered recrudescent because of the low (< 5%) probability of repeated occurrence by chance in the same patient. This approach allows studies of antimalarial drug treatment to be conducted in areas of low transmission since recrudescences can be distinguished confidently from newly acquired infections.

Original publication

DOI

10.4269/ajtmh.1999.60.14

Type

Journal article

Journal

Am J Trop Med Hyg

Publication Date

01/1999

Volume

60

Pages

14 - 21

Keywords

Alleles, Animals, Antigens, Protozoan, DNA, Protozoan, Drug Resistance, Multiple, Gene Frequency, Genetic Markers, Genetic Variation, Genotype, Humans, Malaria, Falciparum, Plasmodium falciparum, Polymerase Chain Reaction, Polymorphism, Restriction Fragment Length, Recurrence, Thailand